LifeStance Health Group, Inc. (LFST) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "LFST"
      ],
      "issuer_cik": "0001845257",
      "owner_cik": "0001865531",
      "accession_number": "0001193125-26-461382",
      "form_type": "4",
      "filing_date": "2026-11-13",
      "period_of_report": "2026-11-10",
      "issuer_name": "LifeStance Health Group, Inc.",
      "issuer_trading_symbol": "LFST",
      "owner_name": "Pardo Ryan",
      "is_director": false,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "See Remarks",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-11-10",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 587920,
      "transaction_price_per_share": 14.58,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 505446,
      "transaction_value": 8571873.6,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $14.285 to $14.7878 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."
        },
        {
          "id": "F2",
          "description": "Represents shares sold pursuant to a plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) that was adopted on August 11, 2026."
        }
      ],
      "remarks": "Chief Legal Officer and Secretary"
    },
    {
      "tickers": [
        "LFST"
      ],
      "issuer_cik": "0001845257",
      "owner_cik": "0001865531",
      "accession_number": "0001193125-26-461382",
      "form_type": "4",
      "filing_date": "2026-11-13",
      "period_of_report": "2026-11-10",
      "issuer_name": "LifeStance Health Group, Inc.",
      "issuer_trading_symbol": "LFST",
      "owner_name": "Pardo Ryan",
      "is_director": false,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "See Remarks",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-11-10",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 2216585,
      "transaction_price_per_share": 14.58,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 334935,
      "transaction_value": 32317809.3,
      "direct_or_indirect": "I",
      "nature_of_ownership": "By Trust",
      "footnotes": [
        {
          "id": "F3",
          "description": "Represents shares sold pursuant to a plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) that was adopted on August 10, 2026."
        },
        {
          "id": "F4",
          "description": "The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $14.285 to $14.7878 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."
        },
        {
          "id": "F5",
          "description": "Shares held of record by Kimberly Pardo Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities and Exchange Act of 1934 or for any other purpose."
        }
      ],
      "remarks": "Chief Legal Officer and Secretary"
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.